Physician profile
Peggy Heis
NPI 1609878164
$526.72
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $188 · 2021: $54.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.92 | 2019-2021 | |
| Ascend Therapeutics US, LLC | $30.50 | 2021 | |
| Mission Pharmacal Company | $28.57 | 2019 | |
| Therapeuticsmd, INC. | $26.74 | 2019 | |
| Boston Scientific Corporation | $26.53 | 2019 | |
| Avion Pharmaceuticals | $17.15 | 2019 | |
| Coopersurgical, INC. | $15.42 | 2020 | |
| Merck Sharp & Dohme LLC | $14.10 | 2019 | |
| Exeltis, USA INC. | $12.96 | 2021 | |
| Pfizer INC. | $11.97 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Heis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.